tradingkey.logo

Inovio Pharmaceuticals Inc <INO.OQ> expected to post a loss of 74 cents a share - Earnings Preview

ReutersMay 9, 2025 8:39 PM
  • Inovio Pharmaceuticals Inc INO.OQ INO.O is expected to show no change in quarterly revenue when it reports results on May 13 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Inovio Pharmaceuticals Inc is for a loss of 74 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Inovio Pharmaceuticals Inc is $7.50​, above​ its last closing price of $1.82. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.79

-0.84

-0.60

Beat

28.3

Sep. 30 2024

-1.14

-1.15

-0.89

Beat

22.6

Jun. 30 2024

-1.12

-1.10

-1.19

Missed

-8​

Mar. 31 2024

-1.01

-1.00

-1.31

Missed

-30.6

​​Dec. 31 2023

-1.42

-1.27

-1.12

Beat

11.6

Sep. 30 2023

-1.50

-1.52

-1.56

Missed

-2.6​

Jun. 30 2023

-1.81

-1.74

-1.56

Beat

10.3

Mar. 31 2023

-1.76

-1.74

-1.92

Missed

-10.3

This summary was machine generated May 9 at 20:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI